Health Care · Nasdaq Copenhagen. Last price 3 469.00 DKK (-0.80% on the day). Raven's AI 12-month target: 3 650.00 DKK. Updated 2026-11-20.
Paper-trade Genmab free with 100 000 fake NOK and compete with other players on Raven Trading Game.
Raven's AI sets a 12-month target of 3 650.00 DKK (+4.38% from 3 497.00 when it was set on 2026-11-20). Conviction: low.
Catalysts: Oncology program data readout; Strategic partnership; M&A activity
Risks: Clinical trial setback; Competitive pressure; Market sentiment reversal
Q3 2026 earnings per share: 37.53 DKK against 22.99 expected (beat by 63.3%). EPS estimates for 2026: 84.50 DKK (7 analysts), 2027: 116.75 DKK (8 analysts). The 2026 estimate has moved +6.0% over 90 days.
Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot
More Health Care stocks on Nasdaq Copenhagen: AMBU-B Ambu · BAVA Bavarian Nordic · COLO-B Coloplast · DEMANT Demant · GN GN Store Nord · NOVO-B Novo Nordisk · ZEAL Zealand Pharma